AMENDMENT AND SUPPLEMENT TO THE DEFINITIVE PROXY STATEMENT
The following disclosures in this Current Report on Form 8-K supplement, and should be read in conjunction with, the disclosures contained in the Company’s definitive proxy statement (the “Definitive Proxy Statement”), filed with the Securities and Exchange Commission (the “SEC”) on April 21, 2023, which in turn should be read in its entirety. To the extent the information set forth herein differs from or updates information contained in the Definitive Proxy Statement, the information set forth herein shall supersede or supplement the information in the Definitive Proxy Statement. All other information in the Definitive Proxy Statement remains unchanged.
As provided in the Definitive Proxy Statement, the Company is seeking stockholder approval of, among other things, the Extension Amendment Proposal and the Trust Amendment Proposal. The purpose of the supplemental disclosures is to provide information about (i) the postponement of the Special Meeting related to the Definitive Proxy Statement, (ii) the resulting extension of the deadline for delivery of redemption and redemption withdrawal requests from the Company’s stockholders to the Company’s transfer agent, (iii) the disclosure that, our Sponsor or its designees has agreed to loan us, for each one-month period during the Extension, the lesser of (x) $0.04 per public share that remains outstanding (and has not been redeemed) and (y) $160,000 and (iv) an updated risk factor.
Terms used herein, unless otherwise defined, have the meanings set forth in the Definitive Proxy Statement. For the avoidance of doubt, references to “public shares” does not include any shares of Class B common stock (or any shares of Class A common stock that are issued upon conversion of any shares of Class B common stock).
Special Meeting Date
On May 12, 2023, the Company issued a press release announcing that it has determined to postpone (the “Postponement”) the date of the Special Meeting from May 12, 2023 to May 19, 2023. As a result of this change, the Special Meeting will now be held at 12:00 p.m. Eastern Time on May 19, 2023 virtually at https://www.cstproxy.com/egacquisition/2023 or by dialing (within the U.S. and Canada) 1 800-450-7155 (or +1 857-999-9155 if attendees are located outside the U.S. and Canada), or at such other time, on such other date and at such other place to which the meeting may be postponed or adjourned.
Extension of Redemption Deadline
As a result of the Postponement, the previously disclosed deadline of May 10, 2023 (two business days before the Special Meeting) for delivery of redemption requests from the Company’s stockholders to the Company’s transfer agent has been extended to May 17, 2023 (two business days before the postponed Special Meeting). Stockholders who wish to withdraw their previously submitted redemption request may ask to do so prior to the postponed Meeting by requesting that the Company’s transfer agent return such shares by 5:00 p.m. Eastern Time on May 17, 2023. Stockholders who do not wish to withdraw their previously submitted redemption requests need not take any further action.
Extension Period Loans
If the Extension Amendment Proposal and the Trust Amendment Proposal are approved and the Extension is implemented, our Sponsor or its designees has agreed to loan to us, for each one-month period during the Extension (each, a “Monthly Extension Period”), the lesser of (a) $0.04 per public share that remains outstanding (and has not been redeemed) as of the last day of such Monthly Extension Period (or, in the case of the initial Loan, as of May 28, 2023) and (b) $160,000, to be funded by our Sponsor not later than seven calendar days following the last day of each such Monthly Extension Period (or, in the case of the Initial Loan, no later than June 5, 2023) (the “Loans”). Each Loan will be deposited in the Trust Account. The Loans will not occur if the Extension Amendment Proposal and the Trust Amendment Proposal are not approved or the Extension is not implemented. In no event will the Sponsor be required to make more than seven Loans (i.e., one Loan in respect of each Monthly Extension Period, if applicable, to the extent the Extension is implemented for the full seven months) and, in the event the Extension is implemented for less than the full seven months, the obligation to make any Loans will only apply through the last Monthly Extension Period that is elected by the Company. The amount of the Loans will not bear interest and will be repayable by us to our Sponsor or its designees upon consummation of an initial business combination. The Company will have the sole discretion whether to extend the date by which the Company must complete a business combination at the request of our Sponsor and if the Company determines not to extend, our Sponsor’s obligation to make Loans following such determination will immediately terminate. If we opt not to utilize any remaining portion of the Extension, then we will liquidate and dissolve promptly in accordance with the Company’s certificate of incorporation.
- 3 -